In addition, growing data suggest that the inhibition of HDAC can ameliorate clinical manifestations of diabetic kidney disease and phenotypes such as fibrosis, inflammation, cell death, and albuminuria [59–61]. This evidence concerns the gene HDAC9 and diabetic kidney disease.